AGITG Abstracts to be presented at ASCO include ICECREAM and INTEGRATE II. They are now available online.
Also to be presented is the SCOT trial conducted in collaboration with the Cancer Research UK Clinical Trials Unit, Glasgow and the Oncology Clinical Trials Office, Oxford.
Final DFS results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer. | 2017 ASCO Annual Meeting Abstracts